p85β alters response to EGFR inhibitor in ovarian cancer through p38 MAPK-mediated regulation of DNA repair

Autor: Mak, Victor CY, Li, Xinran, Rao, Ling, Zhou, Yuan, Tsao, Sai-Wah, Cheung, Lydia WT

Publikováno v: In Neoplasia July 2021 23(7):718-730

Drugging IGF-1R in cancer: New insights and emerging opportunities.

Autor: Wang P; School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China., Mak VC; School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China., Cheung LW; School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.

Publikováno v: Genes & diseases [Genes Dis] 2022 Mar 23; Vol. 10 (1), pp. 199-211. Date of Electronic Publication: 2022 Mar 23 (Print Publication: 2023).